Resonant Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,491
Closed -$542K 477
2025
Q3
$542K Buy
5,491
+720
+15% +$71.3K 0.03% 235
2025
Q2
$436K Buy
4,771
+354
+8% +$34.2K 0.03% 259
2025
Q1
$501K Sell
4,417
-83
-2% -$8.88K 0.03% 210
2024
Q4
$476K Buy
4,500
+207
+5% +$22.2K 0.03% 212
2024
Q3
$464K Sell
4,293
-174
-4% -$19K 0.03% 219
2024
Q2
$486K Buy
4,467
+407
+10% +$48K 0.04% 208
2024
Q1
$537K Buy
4,060
+24
+0.6% +$3K 0.05% 195
2023
Q4
$492K Buy
4,036
+426
+12% +$47.5K 0.05% 183
2023
Q3
$406K Buy
3,610
+236
+7% +$30K 0.04% 183
2023
Q2
$492K Buy
3,374
+16
+0.5% +$2.17K 0.05% 169
2023
Q1
$435K Buy
3,358
+58
+2% +$7.28K 0.05% 175
2022
Q4
$422K Buy
3,300
+228
+7% +$26.5K 0.05% 182
2022
Q3
$322K Buy
3,072
+149
+5% +$16.4K 0.05% 184
2022
Q2
$308K Sell
2,923
-26
-0.9% -$3.08K 0.05% 196
2022
Q1
$378K Buy
2,949
+258
+10% +$31.1K 0.06% 164
2021
Q4
$332K Buy
2,691
+232
+9% +$30.4K 0.05% 164
2021
Q3
$350K Buy
2,459
+769
+46% +$113K 0.06% 153
2021
Q2
$264K Buy
1,690
+49
+3% +$7.94K 0.05% 159
2021
Q1
$255K Buy
1,641
+32
+2% +$4.96K 0.05% 161
2020
Q4
$241K Sell
1,609
-85
-5% -$12K 0.06% 162
2020
Q3
$224K Sell
1,694
-470
-22% -$61.4K 0.06% 151
2020
Q2
$251K Buy
+2,164
New +$249K 0.07% 157

Other funds holding ZBH

Resonant Capital Advisors's ZBH Position: Q4 2025 in Review

Resonant Capital Advisors sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 5,491 shares — an estimated $542K sold.

Resonant Capital Advisors first reported a position in ZBH in Q2 2020 and held it in 22 quarters. The position peaked at $542K in Q3 2025. 946 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Resonant Capital Advisors reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Resonant Capital Advisors sold 5,491 Zimmer Biomet shares in Q4 2025, an estimated $542K.
  • Resonant Capital Advisors first reported a position in Zimmer Biomet in Q2 2020 and held it in 22 quarters.
  • Resonant Capital Advisors's Zimmer Biomet position peaked at $542K in Q3 2025.
  • 946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Resonant Capital Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.